X
Home
About Us
Disease Solutions
Aortic Valve Disease
Pulmonic Valve Disease
Mitral/Tricuspid Valve Disease
Hypertension Diseases
Hypertrophic Cardiomyopathy
News
Careers
Investor Relations
Corporate Governance
Announcement
Download
中
EN
中
EN
About Us
Disease Solutions
Aortic Valve Disease
Pulmonic Valve Disease
Mitral/Tricuspid Valve Disease
Hypertension Diseases
Hypertrophic Cardiomyopathy
News
Careers
Investor Relations
Corporate Governance
Announcement
Download
NEWS
NEWS
Select year
2022
2021
2020
2019
2018
2022.04.27
Medtech Acquires the ISO27001，ISO14001 and ISO45001 Certifications
2022.04.14
Venus Medtech Testing Center Receives National CNAS Laboratory Accreditation Certificate
2022.04.12
Venus-Neo, expandable dry-tissue valve, completes its first case in FIM clinical trial
2022.04.11
VenusP-Valve obtains CE marking under MDR and debuts in Europe as China’s first valve prod···
2022.04.01
Venus Medtech announces 2021 annual results: pacesetter in China and breakthrough-maker wo···
2022.03.18
Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercializati···
2022.03.01
Venus MedTech to establish global heart valve innovation center in Israel
2022.01.26
Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve
2022.01.17
Venus Medtech wins Most Valuable Pharmaceutical and Medical Company Award at Golden Hong K···
2021.12.22
Venus Medtech completes FIM clinical use of Venus-PowerX, the world’s first fully-released···
<
1
2
3
4
5
>